S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling
Authors
Keywords
-
Journal
BASIC RESEARCH IN CARDIOLOGY
Volume 107, Issue 2, Pages -
Publisher
Springer Nature
Online
2012-02-09
DOI
10.1007/s00395-012-0250-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Toll-Like Receptor-4 Modulates Survival by Induction of Left Ventricular Remodeling after Myocardial Infarction in Mice
- (2014) A. Riad et al. JOURNAL OF IMMUNOLOGY
- Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation
- (2011) Junxi Wu et al. BASIC RESEARCH IN CARDIOLOGY
- Class A scavenger receptor attenuates myocardial infarction-induced cardiomyocyte necrosis through suppressing M1 macrophage subset polarization
- (2011) Yulong Hu et al. BASIC RESEARCH IN CARDIOLOGY
- Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction
- (2011) Victor Dayan et al. BASIC RESEARCH IN CARDIOLOGY
- HMGB1: the missing link between diabetes mellitus and heart failure
- (2010) H. Christian Volz et al. BASIC RESEARCH IN CARDIOLOGY
- Enhanced Expression of the S100A8/A9 Complex in Acute Myocardial Infarction Patients
- (2010) Takashi Katashima et al. CIRCULATION JOURNAL
- The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells
- (2010) Karin Loser et al. NATURE MEDICINE
- TNFα in atherosclerosis, myocardial ischemia/reperfusion and heart failure
- (2010) Petra Kleinbongard et al. PHARMACOLOGY & THERAPEUTICS
- Peroxisome proliferator-activated receptor-γ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor
- (2009) Sang-Hyun Ihm et al. BASIC RESEARCH IN CARDIOLOGY
- Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury
- (2009) Kevin Croce et al. CIRCULATION
- Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
- (2009) Stephane Heymans et al. EUROPEAN JOURNAL OF HEART FAILURE
- RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model
- (2008) Alexey Aleshin et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways
- (2008) Chengbo Sun et al. BASIC RESEARCH IN CARDIOLOGY
- Innate immunity and myocardial adaptation to ischemia
- (2008) Hanne Støre Valeur et al. BASIC RESEARCH IN CARDIOLOGY
- High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart
- (2008) Martin Andrassy et al. CIRCULATION
- S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products
- (2008) John H. Boyd et al. CIRCULATION RESEARCH
- RAGE and Modulation of Ischemic Injury in the Diabetic Myocardium
- (2008) L. G. Bucciarelli et al. DIABETES
- The calcium binding protein S100A9 is essential for pancreatic leukocyte infiltration and induces disruption of cell–cell contacts
- (2008) Jürgen Schnekenburger et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The myocardial JAK/STAT pathway: From protection to failure
- (2008) K BOENGLER et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started